Cross-resistance to human cationic antimicrobial peptides and to polymyxins mediated by the plasmid-encoded MCR-1?
Authors:
- 1 September 2017
- journal article
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 23 (9) , 676.e1-676.e5
Abstract
No abstract availableKeywords
Funding Information
- University of Fribourg (16009294)
- Novartis Foundation for Medical-biological Research
This publication has 19 references indexed in Scilit:
- Mechanisms and consequences of bacterial resistance to antimicrobial peptidesDrug Resistance Updates, 2016
- Plasmid-mediated colistin resistance: an additional antibiotic resistance menaceClinical Microbiology and Infection, 2016
- Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological studyThe Lancet Infectious Diseases, 2016
- Phosphoethanolamine Transferase LptA in Haemophilus ducreyi Modifies Lipid A and Contributes to Human Defensin Resistance In VitroPLOS ONE, 2015
- Colistin, mechanisms and prevalence of resistanceCurrent Medical Research and Opinion, 2015
- Mechanisms of Antimicrobial Peptide Resistance in Gram-Negative BacteriaAntibiotics, 2014
- Clinical Use of Colistin Induces Cross-Resistance to Host Antimicrobials in Acinetobacter baumanniimBio, 2013
- Characterization of Unique Modification of Flagellar Rod Protein FlgG by Campylobacter jejuni Lipid A Phosphoethanolamine Transferase, Linking Bacterial Locomotion and Antimicrobial Peptide ResistanceJournal of Biological Chemistry, 2012
- Polymyxin B for the treatment of multidrug-resistant pathogens: a critical reviewJournal of Antimicrobial Chemotherapy, 2007
- The role of cationic antimicrobial peptides in innate host defencesTrends in Microbiology, 2000